These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36373501)

  • 41. Complex health care interventions: Characteristics relevant for ethical analysis in health technology assessment.
    Lysdahl KB; Hofmann B
    GMS Health Technol Assess; 2016; 12():Doc01. PubMed ID: 27066147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Practical tools and methods for health technology assessment in Europe: structures, methodologies, and tools developed by the European Network for Health Technology Assessment, EUnetHTA.
    Kristensen FB; Lampe K; Chase DL; Lee-Robin SH; Wild C; Moharra M; Garrido MV; Nielsen CP; Røttingen JA; Neikter SA; Bistrup ML;
    Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():1-8. PubMed ID: 20030885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hormone treatment of children and adolescents with gender dysphoria: an ethical analysis.
    Abel BS
    Hastings Cent Rep; 2014 Sep; 44 Suppl 4():S23-7. PubMed ID: 25231782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How does HTA addresses current social expectations? An international survey.
    Gagnon H; Legault GA; Bellemare CA; Parent M; Dagenais P; K-Bédard S; Tapin D; Bernier L; Béland JP; Daniel CÉ; Patenaude J
    Int J Technol Assess Health Care; 2020 Oct; 37():e9. PubMed ID: 33109281
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beyond the Black Box Approach to Ethics! Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".
    Sandman L; Gustavsson E
    Int J Health Policy Manag; 2016 Apr; 5(6):393-4. PubMed ID: 27285520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ethical, legal, and social issues in health technology assessment for prenatal/preconceptional and newborn screening: a workshop report.
    Potter BK; Avard D; Entwistle V; Kennedy C; Chakraborty P; McGuire M; Wilson BJ
    Public Health Genomics; 2009; 12(1):4-10. PubMed ID: 19023190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Policy making and roles of health technology assessment.
    Tantivess S
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S88-99. PubMed ID: 19253491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integration of health technology assessment recommendations into organizational and clinical practice: A case study in Catalonia.
    Gagnon MP; Sánchez E; Pons JM
    Int J Technol Assess Health Care; 2006; 22(2):169-76. PubMed ID: 16571192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Application of HTA research on policy decision-making.
    Youngkong S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S119-26. PubMed ID: 24964709
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Implementation Road Map of Health Technology Assessment in Middle-Income Countries: The Case of Jordan.
    Almomani E; Alabbadi I; Fasseeh A; Al-Qutob R; Al-Sharu E; Hayek N; Tarawneh MR; Kaló Z
    Value Health Reg Issues; 2021 Sep; 25():126-134. PubMed ID: 34015521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ethics in HTA: Examining the "Need for Expansion".
    Abrishami P; Oortwijn W; Hofmann B
    Int J Health Policy Manag; 2017 Oct; 6(10):551-553. PubMed ID: 28949470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. STAKEHOLDER INVOLVEMENT IN THE HEALTH TECHNOLOGY ASSESSMENT PROCESS IN LATIN AMERICA.
    Pichon-Riviere A; Soto N; Augustovski F; Sampietro-Colom L
    Int J Technol Assess Health Care; 2018 Jan; 34(3):248-253. PubMed ID: 29888698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. WHY PATIENTS SHOULD BE INVOLVED IN HEALTH TECHNOLOGY ASSESSMENT.
    Wale J; Scott AM; Hofmann B; Garner S; Low E; Sansom L
    Int J Technol Assess Health Care; 2017 Jan; 33(1):1-4. PubMed ID: 28528585
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ethical evaluation in health technology assessment reports: an eclectic approach.
    Autti-Rämö I; Mäkelä M
    Int J Technol Assess Health Care; 2007; 23(1):1-8. PubMed ID: 17234010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COMPREHENSIVE ASSESSMENT OF COMPLEX TECHNOLOGIES: INTEGRATING VARIOUS ASPECTS IN HEALTH TECHNOLOGY ASSESSMENT.
    Lysdahl KB; Mozygemba K; Burns J; Brönneke JB; Chilcott JB; Ward S; Hofmann B
    Int J Technol Assess Health Care; 2017 Jan; 33(5):570-576. PubMed ID: 28780928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Which Criteria are Considered and How are They Evaluated in Health Technology Assessments? A Review of Methodological Guidelines Used in Western and Asian Countries.
    Wang Y; Qiu T; Zhou J; Francois C; Toumi M
    Appl Health Econ Health Policy; 2021 May; 19(3):281-304. PubMed ID: 33426626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PERSPECTIVE: SOME CONCLUSIONS FROM MY LIFE IN HEALTH TECHNOLOGY ASSESSMENT.
    Banta HD
    Int J Technol Assess Health Care; 2018 Jan; 34(2):131-133. PubMed ID: 29609663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.
    Tantivess S; Teerawattananon Y; Mills A
    Pharmacoeconomics; 2009; 27(11):931-45. PubMed ID: 19888793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact assessment of Iran's health technology assessment programme.
    Yazdizadeh B; Mohtasham F; Velayati A
    Health Res Policy Syst; 2018 Feb; 16(1):15. PubMed ID: 29471838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.